Nurix Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 600,000 | 0.932% |
Individual Insiders | 694,122 | 1.08% |
Hedge Funds | 8,365,141 | 13% |
General Public | 12,055,851 | 18.7% |
Institutions | 42,641,421 | 66.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,042,150 | US$117.6m | 31.9% | no data | |||
4,483,016 | US$87.3m | 37.7% | 3.98% | |||
3,882,125 | US$75.6m | 0% | 0.91% | |||
2,997,830 | US$58.4m | 0% | 1.68% | |||
2,729,336 | US$53.1m | 196% | no data | |||
2,635,338 | US$51.3m | -17.5% | 0.38% | |||
2,584,300 | US$50.3m | -0.53% | no data | |||
2,485,087 | US$48.4m | -19.8% | 0.01% | |||
2,196,169 | US$42.8m | -8.11% | no data | |||
1,499,368 | US$29.2m | 197% | 0.01% | |||
1,236,753 | US$24.1m | -55% | 0.09% | |||
1,132,397 | US$22.0m | -37.9% | 2.4% | |||
1,115,000 | US$21.7m | 680% | 2.08% | |||
1,100,335 | US$21.4m | 1.83% | no data | |||
966,453 | US$18.8m | -3.36% | no data | |||
892,110 | US$17.4m | -2.83% | 0.05% | |||
810,253 | US$15.8m | 17.4% | 3.15% | |||
726,941 | US$14.2m | -6.03% | 0.01% | |||
642,190 | US$12.5m | 3.2% | no data | |||
434,413 | US$8.5m | 73.5% | 0.04% | |||
417,619 | US$8.1m | -21.6% | no data | |||
404,010 | US$7.9m | -3.07% | no data | |||
374,249 | US$7.3m | -0.88% | 0.01% | |||
357,287 | US$7.0m | 0% | 0.01% | |||
314,762 | US$6.1m | 0% | 0.07% |